Genetic variants and susceptibility to neurological complications following West Nile virus infection

Journal of Infectious Diseases

Volumn 204, Issue 7, 2011, Pages 1031-1037

  Loeb, Mark ^a   Eskandarian, Sasha ^a   Rupp, Mark ^c   Fishman, Neil ^d   Gasink, Leanne ^d   Patterson, Jan ^e   Bramson, Jonathan ^a   Hudson, Thomas J ^b   Lemire, Mathieu ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANANYLAMINOPEPTIDASE GENE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE REPLICATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REPLICATION FACTOR C1 GENE; SCN1A GENE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS GENE; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

EID: 80052425321     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir493     Document Type: Article

References (32)

1. Petersen L.R., Hayes E.B. West Nile virus in the Americas. Med Clin North Am 2008; 92:1307-1322
2. Gubler D.J. The continuing spread of West Nile virus in North America. Clin Infect Dis 2007; 45:1039-1046 (Pubitemid 47580356)
3. Kramer L.D., Styer L.M., Ebel G.D. A global perspective on the epidemiology of West Nile virus. Annu Rev Entomol 2008; 53:61-81. (Pubitemid 351341931)
4. Mostashari F., Bunning M.L., Kitsutani P.T., et al. Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet 2001; 358:261-264 (Pubitemid 32738963)
5. Brown J.A., Factor D.L., Tkachenko N., et al. West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector Borne Zoonotic Dis 2007; 7:479-488
6. O'Leary D.R., Marfin A.A., Montgomery S.P., et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004; 4:61-70. (Pubitemid 38745025)
7. Davis L.E., DeBiasi R., Goade D.E., et al. West Nile virus neuroinvasive disease. Ann Neurol 2006; 60:286-300. (Pubitemid 44520233)
8. Pepperell C., Rau N., Krajden S., et al. West Nile virus infection in 2002: Morbidity and mortality among patients admitted to hospital in south central Ontario. CMAJ 2003; 168:1399-1405 (Pubitemid 36714037)
9. Sejvar J.J., Haddad M.B., Tierney B.C., et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290:511-515 (Pubitemid 37430505)
10. Smith R.D., Konoplev S., DeCourten-Myers G., et al. West Nile virus encephalitis with myositis and orchitis. Hum Pathol 2004; 35:254-258 (Pubitemid 38240910)
11. Agamanolis D.P., Leslie M.J., Caveny E.A., et al. Neuropathological findings in West Nile virus encephalitis: A case report. Ann Neurol 2003; 54:547-551 (Pubitemid 37176556)
12. Gyure K.A. West Nile virus infections. J Neuropathol Exp Neurol 2009; 68:1053-1060
13. Iwamoto M., Jernigan D.B., Guasch A., et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196-2203 (Pubitemid 36618130)
14. Kumar D., Drebot M.A., Wong S.J., et al. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 2004; 4:1883-1888 (Pubitemid 39434451)
15. Kumar D., Prasad G.V., Zaltzman J., et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 2004; 77:399-402. (Pubitemid 38209739)
16. Glass W.G., McDermott D.H., Lim J.K., et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 2006; 203:35-40. (Pubitemid 43139642)
17. Lim J.K., Louie C.Y., Glaser C., et al. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: A meta-analysis of 4 cohorts in the US epidemic. J Infect Dis 2008; 197:262-265 (Pubitemid 351263445)
18. Lim J.K., McDermott D.H., Lisco A., et al. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis 2010; 201:178-185
19. Bonnevie-Nielsen V., Field L.L., Lu S., et al. Variation in antiviral 2′,5′-oligoadenylate synthetase (2′5′AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet 2005; 76:623-633 (Pubitemid 40432169)
20. Yakub I., Lillibridge K.M., Moran A., et al. Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylate synthetase and RNase L in patients hospitalized with West Nile virus infection. J Infect Dis 2005; 192:1741-1748 (Pubitemid 41587824)
21. Lim J.K., Lisco A., McDermott D.H., et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 2009; 5:e1000321.
22. Centers for Disease Control and Prevention. Encephalitis or meningitis, arboviral (includes California serogroup, Eastern equine, St. Louis, Western equine, West Nile, Powassan). 2001. Case Definition. http://www.cdc.gov/osels/ ph-surveillance/nndss/casedef/encephalitiscurrent.htm Accessed 17 August 2011.
23. The Wellcome Trust Case Control Consortium. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39:1329-1337
24. The International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449:851-861
25. Clayton D.G. Sex chromosomes and genetic association studies. Genome Med 2009; 1:110.
26. Skol A.D., Scott L.J., Abecasis G.R., Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38:209-213 (Pubitemid 43177235)
27. Okumura K., NogamiM., Taguchi H., et al. Assignment of the 36.5-kDa (RFC5), 37-kDa (RFC4), 38-kDa (RFC3), and 40-kDa (RFC2) subunit genes of human replication factor C to chromosome bands 12q24.2-q24.3, 3q27, 13q12.3-q13, and 7q11.23. Genomics 1995; 25:274-278
28. Baulac S., Gourfinkel-An I., Picard F., et al. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet 1999; 65:1078-1085 (Pubitemid 30462965)
29. Yeager C.L., Ashmun R.A., Williams R.K., et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 1992; 357:420-422
30. Uchiumi F., Ohta T., Tanuma S. Replication factor C recognizes 5-prime-phosphate ends of telomeres. Biochem Biophys Res Commun 1996; 229:310-315 (Pubitemid 27013749)
31. Heath S.C., Gut I.G., Brennan P., et al. Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet 2008; 16:1413-1429
32. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004; 10:1366-1373 (Pubitemid 40022719)